Benzinga's Top Pre-Market NASDAQ Gainers (CSCX, ACLS, TSPT, QGEN)
Cardiac Science Corporation (NASDAQ: CSCX) surged 9.05% to $2.29 in the pre-market session. Opto Circuits has agreed to purchase all the outstanding shares of CSCX for $2.30 per share, representing a 10% premium to the CSCX's closing price on October 18.
Axcelis Technologies Inc (NASDAQ: ACLS) added 2.90% to $2.13 in the pre-market session. ACLS has received multiple system order from major chipmakers for Integra photoresist dry strip cleaning system.
Transcept Pharmaceuticals Inc (NASDAQ: TSPT) moved up 2.12% to $6.75 in the pre-market session. TSPT has planned to resubmit a new drug application (NDA) with US Food and Drug Administration in the first quarter of 2011 for its sleep-disorder drug Intermezzo.
Qiagen NV (NASDAQ: QGEN) rose 0.93% to $18.47 in the pre-market trading. QGEN's earnings are likely to surge by 47.96% this year.
Read more from Benzinga's Markets.
